| Investor Type | Firm |
| Investing | United States |
| Investment Range | $10,000,000 - $10,000,000 |
Health2047 is a venture studio that operates under the principles of integrated innovation within the healthcare sector, heavily supported by the American Medical Association. They focus on guiding and developing ideas that have the potential to bring system-level improvements to healthcare.
Their mission resonates through the entire cycle of startup development—from the initial hiring phase all the way to seed funding—aiming to propel ventures that can generate significant healthy returns.
Health2047's strategy encompasses a bold approach to partnering with entrepreneurs who are at the forefront of transforming healthcare through various means including improved diagnostic processes, advanced technology utilization, groundbreaking research methodologies, and enhanced care delivery.
Their portfolio showcases companies like Evidium, Zing Health, SiteBridge Research, Phenomix Sciences, Medcurio, and more—each reflecting the company's commitment to innovation within the healthcare realm. Furthermore, Health2047 provides a fertile ecosystem for biotech companies requiring expertise from multiple disciplines such as biology, clinical evidence, data management, and patient care.
Additionally, they offer resources like case studies and a monthly newsletter, 'Healthy Returns', aimed at providing insights for founders interested in impactful healthcare ventures. Their investment parameters are specific, with both the minimum and maximum investment amount set at $10 million, reflecting a targeted and substantial commitment to their chosen startups.

